LABORATORY PROFILES OF LIBYAN PATIENTS ON HEMODIALYSIS: A RETROSPECTIVE STUDY IN TWO MAIN HOSPITALS IN BENGHAZI CITY.

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy/ University of Benghazi, Benghazi, Libya.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • How to Cite This Article
  • Corresponding Author

Libya has a high prevalence of risk factors for chronic kidney disease. The majority of Libyan patients with end-stage kidney diseases remain dialysis-dependent. Regular assessment of laboratory parameters is the only way to reduce the risk of mortality in chronic kidney disease patients. Current study aimed at analyzing laboratory profiles of Libyan patients on hemodialysis and admitted to Nephrology Units in two main hospitals; Benghazi Medical Center and Al-Hawari Hospital in Benghazi ?Libya, during the period 3rdJuly to 7th August 2016. A structured form was used to record data collected from patients? files. Collected data included admission date, medical history of patient, treatment history of the patient and importantly laboratory tests? results, specifically white blood cells (WBC), hemoglobin (HB), phosphate, calcium, sodium, creatinin, urea, albumin and glucose. Males represented 68% of study sample, taking n consideration that 40% of study sample started dialysis in the last 4-6 years. There was a significant difference between the values of (WBC, HB, phosphate, calcium, sodium, creatinin, urea, and glucose) at time of measurement compared to values before starting dialysis. Patients on maintenance dialysis in Libya have high incidence and prevalence of hypertension, hyperphosphatemia and anemia. Actions need to be taken to improve dialysis patients? care and also the choices of their medications.

  1. Kadiki, O.A., Roaeid, R.B. (2001) Prevalence of diabetes mellitus and impaired glucose tolerance in Benghazi Libya. Diabetes Metab., 27(6):647-654
  2. Rao, G.M. (1992) Diabetes mellitus in Libya: a retrospective study. Indian J. Med. Sci., 46(6):174-181
  3. Goleg, F.A., Kong, N.C. and Sahathevan, R. (2014) Dialysis-treated end-stage kidney disease in Libya: epidemiology and risk factors. Int. Urol. Nephrol., 46(8):1581-1587
  4. Alashek, W.A., Mclntyre, C.W. and Taal, M.W. (2011) Provision and quality of dialysis services in Libya. Hemodial. Int., 15(4):444-452
  5. Alashek, W.A., Mclntyre, C.W. and Taal, M.W. (2012) Epidemiology and aetiology of dialysis-related end-stage kidney disease in Libya. BMC Nephrol., 13(33):1-7
  6. Alashek, W.A., Mclntyre, C.W. and Taal, M.W. (2013) Detreminants of survival in patients receiving dialysis in Libya. Hemodial. Int., 17(2):249-255
  7. Usta, A., Shawish, T., Mishra, A., Ehtuish, E.F., Ajaj, H., Milud, N., Shebani, A., Abdulmola, T. and Tajori, U. (2008) Living related kidney transplantation in Libya: a single center experience. Transplant. Proc., 40(10):3428-3433
  8. Ehtuish, E.F., Abouna, G.M., Shebani, A.H., Abdulmola, T.S. and Shawesh, T.Z. (2006) Kidney transplantation in Libya: a North African and Middle Eastern perspective. Exp. Clin. Transplant., 4(1):425-428
  9. Jondeby, M.S., De-Los Santos, G.G., Al-Ghamdi, A.M., Al-Hawas, F.A., Al-Sulaiman, M.H. and Al-Khader, A.A. (2001) Caring for hemodialysis patients in Saudi Arabia. Past, present and future. Saudi Med. J., 22(3):199-204
  10. Auer, J., Oliver, D.O. and Winearls, C.G. (1990): The quality of life of dialysis patients treated with recombinant human erythropoietin.?Scand. J. Urol. Nephrol., Suppl 131: 61?65
  11. Delano, B.G., (1989)Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients. Am. J. Kidney Dis.,?14[2 Suppl 1]:14?18
  12. Avram, M.M., Blaustein, D., Fein, P.A., Goel, N., Chattopadhyay, J. and Mittman, N. (2003) Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin.?Kidney. Int., Suppl 87:?S6?11
  13. Besarab, A., Bolton, W.K., Browne, J.K., Egrie, J.C., Nissenson, A.R., Okamoto, D.M., Schwab, S.J and Goodkin, D.A. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.?N. Engl. J. Med.,?339(9): 584?590
  14. Eschbach, J.W., Abdulhadi, M.H., Browne, J.K., Delano, B.G., Downing, M.R., Egrie, J.C., Evans, R.W., Freidman, E.A., Graber, S.E., Haley, N.R., Korbet, S., Krantz, S.B., Lundin, A.P., Nissenson, A.R., Ogden, D.A., Paganini, E.P., Rader, B., Rutsky, E.A., Stivelman, J., Stone, W.J., Teschan, P., Van Stone, J.C., Van Wyck, D.B., Zuckerman, K. and Adamson, J.W. (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann. Intern. Med., 111:992-1000
  15. Santos, S.F.F., Peixoto, A.J. (2010) Sodium balance in maintenance hemodialysis.?Semin. Dial., 2:549?555.

Salma A. Bukhatwa, Wafa M. Almajbri, Waed T. Alzuwawi, Turkeya Y. Ellgeryni And Narges M. Kablan. (2019); LABORATORY PROFILES OF LIBYAN PATIENTS ON HEMODIALYSIS: A RETROSPECTIVE STUDY IN TWO MAIN HOSPITALS IN BENGHAZI CITY., Int. J. of Adv. Res., 7 (05), 821-825, ISSN 2320-5407. DOI URL: https://dx.doi.org/10.21474/IJAR01/9103

Salma A. Bukhatwa
Department of Pharmacology & Toxicology, University of Benghazi, Benghazi, Libya

DOI:

Article DOI: 10.21474/IJAR01/9103      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9103

Download Full Paper

Download PDF No. of Downloads: 60 | No. of Views: 248